2Hanada, M. et al. Jpn. J.Cancer Res. 1998,89:1229.
3.氨柔比星说明书[Z].,..
同被引文献35
1Ogawa M. Novel anticancer drugs in Japan [J]. J Cancer Res Clin Oncol, 1999, 125 (3-4): 134-140.
2Kurata T, Okamoto I, Tamura K, et al. Amrubicin for non-small-cell lung cancer and small-cell lung cancer [J]. Invest NewDrugs, 2007, 25(5): 499-504.
3Yokota S, Negoro S, Yana T, et al. Phase II study of amrubicin (SM-5887), a 9-amino-anthracycline, in previously untreated paitents with extensive stage small-cell cancer(ES-SCLC) : A West Japan Lung Cancer Group Trial [J]. ProcAm Soc Clin Oncol, 1998, 17 (1) : 450.
4Tririya G, Zanger M. Synthesis of anthracyclinone precursor: 5,12-dihydroxy- 1,3,4-trihydronaphthacene-2,6,11 -quinone [J]. Synth Commun, 2004, 34 (17): 3047-3059.
5Alexander J, Mitscher LA. A short, efficient synthesis of an anthracycline antitumor antibiotic synthon [J]. Tetrahedron Lett, 1978, 19(37):3403-3406.
6Lewis TR, Dickinson WB, Archer S. 1,4-Dimethoxy-5- methyl-6-tetralone and 1,4-dimethoxy-5,5-dimethyl-6- tetralone [J]. JAm Chern Soc, 1952, 74 (21) : 5321-5324.
8Nixon JA, Pioch RP, Schaus JM, et al. Ring-substituted 2-amino-l,2,3,4-tetarhydronaphthalenes: US, 5026707 [P]. 1989-11-26. (CA 1989, 112: 235346).
9Arvidsson LE, Hacksell U, Johansson A, et al. 8-Hydroxy- 2-(alkylamino) tetralins and related compounds as central 5-hydroxytryptamine receptor agonists [J]. J Med Chem, 1984, 27(1): 45-51.
10Manitto P, Sperama G, Monti D, et al. Baker's Yeast Mediated Reduction of Aromatic Ring Substituted 2-Tetralones [J]. Tetrahedron, 1995, 51 (42) : 11531-11546.
